Osteoporosis International

, Volume 22, Issue 4, pp 1227–1236 | Cite as

Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU® study

  • C. Roux
  • C. Cooper
  • A. Díez-Pérez
  • L. Martinez
  • S. Ortolani
  • M. Gitlin
  • G. Möller
  • S. Shepherd
  • N. Freemantle
Original Article

Abstract

Summary

European observational 1-year study assessed osteoporosis and fracture patterns in 3,402 postmenopausal women prescribed osteoporosis medication. Almost 40% of patients had a previous fracture, while 25% had neither fracture nor dual energy X-ray absorptiometry (DXA) diagnosis and were prescribed medication, probably due to other risk factors.

Introduction

This analysis assessed osteoporosis and fracture prevalence in postmenopausal women prescribed osteoporosis treatment in the Prospective Observational Study Investigating Bone Loss Experience in Europe(POSSIBLE EU®).

Methods

Women in this observational, multicenter 1-year study were categorized by fracture history and location at baseline. Baseline characteristics were analyzed according to no DXA and DXA diagnosis (osteoporosis or osteopenia). Fractures occurring during the 1-year follow-up period were recorded.

Results

Of the 3,402 women enrolled, 39% had a previous fracture, of whom 30% had ≥2 fractures. One thousand seven hundred and eighty-four (52%) patients had a DXA diagnosis (osteoporosis 68%, osteopenia 31%, and unknown 1%). Among the osteoporosis patients, 37% had a previous fracture (hip 2.9%, vertebral 8.8%, and non-hip, non-vertebral 25%) and 35% had fractures associated with major trauma. Of the 3,402 women, 1,476 (43%) had no DXA diagnosis; of these, 57% had no fracture (25% of all women). Risk factors varied across patients with and without DXA diagnosis. During the 1-year follow-up period, the fracture incidence in patients with or without a previous fracture at baseline was 4.7% and 1.6%, respectively.

Conclusion

Almost 40% of patients prescribed osteoporosis medication had a previous fracture, highlighting a population with advanced disease. In contrast, 25% of patients had neither a previous fracture nor DXA diagnosis and were prescribed treatment, probably due to other risk factors. There is a need for continued improvement of disease management in European women.

Keywords

Bone Dual energy X-ray absorptiometry Europe Fractures Osteopenia Osteoporosis 

References

  1. 1.
    Hodgson SF, Watts NB, Bilezikian JP et al (2003) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 9:544–564PubMedGoogle Scholar
  2. 2.
    Delmas PD, Marin F, Marcus R et al (2007) Beyond hip: importance of other nonspinal fractures. Am J Med 120:381–387PubMedCrossRefGoogle Scholar
  3. 3.
    Burge R, Dawson-Hughes B, Solomon DH et al (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475PubMedCrossRefGoogle Scholar
  4. 4.
    Lindsay R, Silverman SL, Cooper C et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285:320–323PubMedCrossRefGoogle Scholar
  5. 5.
    Johnell O, Kanis JA, Odén A et al (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15:175–179PubMedCrossRefGoogle Scholar
  6. 6.
    Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375–382PubMedCrossRefGoogle Scholar
  7. 7.
    Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929–1936PubMedCrossRefGoogle Scholar
  8. 8.
    Klotzbuecher CM, Ross PD, Landsman PB et al (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739PubMedCrossRefGoogle Scholar
  9. 9.
    Cauley JA, Thompson DE, Ensrud KC et al (2000) Risk of mortality following clinical fractures. Osteoporos Int 11:556–561PubMedCrossRefGoogle Scholar
  10. 10.
    Fisher ES, Wennberg DE, Stukel TA et al (2003) The implications of regional variations in medicare spending. Part 1: the content, quality, and accessibility of care. Ann Intern Med 138:273–287PubMedGoogle Scholar
  11. 11.
    Bliuc D, Nguyen ND, Milch VE et al (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513–521PubMedCrossRefGoogle Scholar
  12. 12.
    Kanis JA, Burlet N, Cooper C et al (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399–428PubMedCrossRefGoogle Scholar
  13. 13.
    (2009) Dachverband Osteologie. S3-Leitlinie Osteoporose. Version 2009. http://www.dv-osteologie.org/. Accessed on 27th April, 2010
  14. 14.
    Freemantle N, Cooper C, Roux C et al (2010) Baseline observations from the POSSIBLE EU study: characteristics of postmenopausal women receiving bone loss medications. Arch Osteoporos (in press). doi:10.1007/s11657-010-0035-7
  15. 15.
    Harrington JT, Ste-Marie LG, Brandi ML et al (2004) Risedronate rapidly reduces the risk for non-vertebral fractures in women with osteoporosis. Calcif Tissue Int 74:129–135PubMedCrossRefGoogle Scholar
  16. 16.
    Barrett-Connor E, Sajjan SG, Siris ES et al (2008) Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int 19:607–613PubMedCrossRefGoogle Scholar
  17. 17.
    Borgström F, Zethraeus N, Johnell O et al (2006) Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int 17:637–650PubMedCrossRefGoogle Scholar
  18. 18.
    van Geel TA, van Helden S, Gleusens PP et al (2009) Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis 68:99–102PubMedCrossRefGoogle Scholar
  19. 19.
    Adami S, Isaia G, Luisetto G et al (2006) Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study. J Bone Miner Res 21:1565–1570PubMedCrossRefGoogle Scholar
  20. 20.
    Sambrook P, Adami S, Anderson FA et al (2009) Multinational comparison of bone health in women 55 years of age and older. The global longitudinal study of osteoporosis in women [abstract]. Bone 44:S115Google Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2010

Authors and Affiliations

  • C. Roux
    • 1
    • 11
  • C. Cooper
    • 2
    • 3
  • A. Díez-Pérez
    • 4
  • L. Martinez
    • 5
  • S. Ortolani
    • 6
  • M. Gitlin
    • 7
  • G. Möller
    • 8
  • S. Shepherd
    • 9
  • N. Freemantle
    • 10
  1. 1.Department of RheumatologyParis Descartes UniversityParisFrance
  2. 2.MRC Epidemiology Resource CentreUniversity of SouthamptonSouthamptonUK
  3. 3.NIHR Musculoskeletal BRUUniversity of OxfordOxfordUK
  4. 4.Departamento de MedicinaHospital del Mar IMIM-UAB-RETICEFBarcelonaSpain
  5. 5.Société Française de Médecine GénéraleIssy les MoulineauxParisFrance
  6. 6.Istituto Auxologico ItalianoMilanItaly
  7. 7.Health EconomicsAmgen (Europe) GmbHZugSwitzerland
  8. 8.International DevelopmentAmgen (Europe) GmbHZugSwitzerland
  9. 9.Biostatistics, Amgen LtdUxbridgeUK
  10. 10.School of Health and Population SciencesUniversity of BirminghamBirminghamUK
  11. 11.Centre d’Evaluation des Maladies Osseuses–RhumatologieHôpital CochinParisFrance

Personalised recommendations